Checked
Medical Devices; Radiology Devices; Classification of the Radiology Software for Referral of Findings Related to Fibrotic Lung Disease
Final rule · Federal Register document 2026-22180
- Published
- 10/30/2026
- Effective
- 10/30/2026
- Pages
- 4
Summary
Final amendment; final order.
The Food and Drug Administration (FDA) is classifying the radiology software for referral of findings related to fibrotic lung disease into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the radiology software for referral of findings related to fibrotic lung disease. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Details
- Type
- Final rule
- Docket
- Docket No. FDA-2026-N-12254
- CFR parts
- 21 CFR 892
- Topics
- Medical devices, Radiation protection, X-rays
This page summarizes a Federal Register document. Only the official Federal Register text has legal effect. Comment deadlines can be extended or reopened by a later notice.
Source: Office of the Federal Register, via the Federal Register API · Last updated 10/30/2026